Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Immunogen reported $2.26M in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 72K 1000
Astellas Pharma 4503:JP JPY 103B 0
AstraZeneca AZN:LN USD 387M 0
Bluebird Bio BLUE:US USD 1.06M 234K
Eli Lilly LLY:US USD 593.5M 600K
Emergent BioSolutions EBS:US USD 100K 0
Exelixis EXEL:US USD 325K 1000
Halozyme Therapeutics HALO:US USD 132K 3K
Heron Therapeutics HRTX:US USD 1.19M 2K
Immunogen IMGN:US USD 2.26M 1000
MacroGenics MGNX:US USD 618K 1000
Nektar Therapeutics NKTR:US USD 19K 0
Novartis NVS:US USD 842M 48M
Roche Holding ROG:VX CHF 107M 0
Seattle Genetics SGEN:US USD 187K 0